FLEXIBLE CDMO

Aseptic fill-finish.
Built for optionality.

Spanance is building a next-generation aseptic fill-finish CDMO in Portugal, designed to support sterile injectable programs from clinical batches through commercial scale.
Our modular approach combines flexible manufacturing architecture with isolator-based technology, enabling us to adapt to different program sizes, product formats and partner requirements.

ADVANCING SCIENCE,
ENHANCING LIFE

Location

Portugal
(Mação, Santarém)
3,000 m2

cleanroom
footprint

Aseptic            fill-finish

multiple-rooms

Multiple
rooms

with independent
HVAC

1.5 h
from Lisbon

Multi-format RTU

Vials • PFS • Cartridges

Location

Portugal
(Mação, Santarém)
3,000 m2

cleanroom
footprint

Aseptic
fill-finish

Multiple
rooms

with independent
HVAC

1.5 h
from Lisbon

Multi-format
RTU

Vials • PFS • Cartridges

ABOUT

A CDMO that keeps
options open

Spanance is focused on downstream pharmaceutical manufacturing, with aseptic fill-finish at the core of our platform. Our modular approach is designed to accommodate different product formats, batch sizes and stages of development while supporting efficient scale-up and technology transfer.

Modular rooms & flows adaptable to program needs

Aseptic fill-finish from clinical to commercial scale

Vials, pre-filled syringes & cartridges

Peptides, biologics & other injectable therapeutics

ABOUT

A CDMO that keeps
options open

Spanance is focused on downstream pharmaceutical manufacturing, with aseptic fill-finish at the core of our platform. Our modular approach is designed to accommodate different product formats, batch sizes and stages of development while supporting efficient scale-up and technology transfer.

Modular rooms & flows adaptable to program needs

Aseptic fill-finish from clinical to commercial scale

Vials, pre-filled syringes & cartridges

Peptides, biologics & other injectable therapeutics

FACILITIES

Versatile facilities

Our 3,000 m² GMP-designed facility in Mação is being developed around modular, independently controlled production areas and an isolator-based aseptic fill-finish platform.
The facility is designed to support compliance with EU GMP Annex 1, combining controlled manufacturing environments with the flexibility to accommodate different batch sizes, formats and future capacity requirements.

Capabilities

Capabilities in focus

Our platform is being built around flexible aseptic manufacturing, supporting partners as programs progress from clinical supply and technology transfer towards commercial production.

From clinical batches to commercial scale

  • Filling of vials, pre-filled syringes and cartridges
  • Isolator-based aseptic processing
  • Flexible batch sizes and scalable manufacturing programs

Building the path to manufacturing

  • Technology transfer and process scale-up
  • Validation and manufacturing readiness
  • Coordination of analytical and regulatory requirements

Capacity that adapts to the program

  • Modular rooms and manufacturing flows
  • Flexibility across products, formats and batch sizes
  • Expansion pathways aligned with partner and market needs
Partnerships

Open for partnerships

We are engaging with pharmaceutical and biotechnology companies looking for flexible aseptic fill-finish capacity in Europe. If you’re seeking a nimble manufacturing partner – or a site to anchor a program – let’s talk.